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Abstract 
Alkanols and tertiary amine derivative local anesthetics modify the activity of Ca2+-ATPase. In order to investigate the primary 
binding sites, associated to the functional changes, sarcoplasmic reticulum (SR) Ca 2 +-ATPase was labeled with maleimide derivative spin 
labels which bind covalently to SH groups of cysteine residues and allow to probe the regions of the protein close to those residues. The 
EPR measurements showed motional constraints induced by drug-treatment which indicate changes in the enzyme dynamics and 
structure, n-Alkanols are shown to affect some of the protein-bound labels by restricting their motion. There is, however, no correlation 
between the functional effects and the observed motional restriction, in the sense that concentrations of the different alcohols leading to 
the same functional effects do not induce the same degree of restriction. Dibucaine and tetracaine at functional relevant concentrations 
also restrict the movement of protein bound labels. But, in this case, correlation between spectral changes and functional effects is 
observed. 
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1. Introduction 
Anesthetics belong to diverse classes of chemical sub- 
stances having in common the amphipathic character. This 
diversity puts an entangled problem on searching for the 
main targets of these substances and on sorting those 
which are important to the mechanism of anesthesia. It was 
pointed out that large anesthetic oncentrations affect al- 
most any target [1], and that it is important o consider 
only the effects at concentrations relevant o anesthesia. 
On the other hand, review papers [1,2] show how far we 
are from answering the question of what is the real target 
leading to anesthesia nd how anesthetics work at the 
molecular level. With this in mind, clearly, the investiga- 
tion of anesthetic interactions with well characterized bio- 
logical membranes and their correlations with effects on 
membrane function helps to elucidate mechanisms of ac- 
tion, even if these effects occur at concentrations larger 
than those leading to anesthesia. 
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It is known [3] that the potency of an anesthetic in- 
creases roughly in proportion with its lipid/wate r partition 
coefficient, strongly suggesting an amphiphilic site for 
anesthetic molecules. The modification of the lipid/pro- 
tein interface is a possible pathway for anesthetic action 
[4-9], in agreement with the above correlation. However, 
Franks and Lieb have claimed that increasing evidence has 
favoured the view that proteins and not lipids are the 
primary targets for anesthetics [1]. 
The n-alkanols hare the property of general anesthesia. 
At concentrations about one order of magnitude higher 
than those required for general anesthesia they affect the 
function of ion channels, in particular the Ca 2 +-ATPase of 
sarcoplasmic reticulum (SR) [ 10,11 ]. It was shown that the 
enhancement of the ATPase activity and decrease of net 
calcium uptake induced by the n-alkanols is accompanied 
by modifications of the molecular dynamics of the mem- 
brane lipids at the lipid/protein interface [12]. It was 
proposed that the alcohol molecules interfere with the 
protein-lipid interactions creating fluid clusters around the 
proteins, affecting the enzyme conformation, and perturb- 
ing its function [12]. 
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Local anesthetics such as dibucaine and tetracaine exert 
complex effects on the SR. These drugs are known to 
modify the rate of Ca 2+ fluxes (either elease or uptake) 
inducing blockage or enhancement depending upon drug 
concentration and experimental conditions [13-17]. These 
effects have been attributed to binding of local anesthetics 
to the phospholipids of the membrane [13,14], to changes 
in the protein/lipid interface [18], to blockage of Ca 2+ 
channels [15,16] and to direct action on sites of the Ca 2+- 
ATPase [19]. Thus, the complex effects of local anesthetics 
on the functional behaviour of the SR suggest hat these 
agents may have multiple sites of action. Thomas and 
Mahaney reviewed the influence of membrane properties 
on the activity of sarcoplasmic reticulum [20], and a single 
physical model was proposed to explain different func- 
tional effects of local and general anesthetics in SR: 
aggregation i hibits the Ca2+-ATPase, and the oligomeric 
state of this protein is the strong determinant of its enzi- 
matic activity [21,22]. 
Spin-labeling technique using nitroxide-labeled lipids is 
largely employed in membrane research, but the use of 
labels bound to integral membrane proteins is less com- 
mon, Structural and dynamical effects of different drugs on 
proteins may be studied by using maleimide derivative 
nitroxide spin labels [23]. These labels bind covalently to 
SH groups present in cysteine residues, allowing to study 
the regions of the protein close to these groups. The 
Ca2+-ATPase of SR contains 24 cysteine residues whose 
location was inferred from the analysis of the amino-acid 
sequence [24,25]. Among all these sulfhydryl groups there 
are only two very fast reacting groups and another two 
which belong to an intermediate class [26]. 
In this paper, we have used maleimide spin labels 
(MSL) to investigate the effects of n-alkanols and of the 
local anesthetics dibucaine and tetracaine on the protein 
portion of SRV, e.g., Ca 2 +-ATPase, and we correlate these 
effects with previously observed functional effects. 
2. Materials and methods 
2.1. Materials 
SRV from rabbit skeletal muscle prepared basically as 
previously described [27,28] were supplied by Dr. L. de 
Meis' laboratory (Biochemistry Department, Universidade 
Federal do Rio de Janeiro) and stored in liquid nitrogen. 
These samples are rich in Ca2+-ATPase which constitutes 
approx. 90% of the protein content, n-Alkanols were pur- 
chased from Merck, local anesthetics (dibucaine and tetra- 
caine hydrochloride) and the maleimide derivative spin 
labels 3-(2-[2-maleimidoethoxy]ethylcarbamoyl)-proxyl 
(MSL-4), 3-(2-maleimidoethylcarbamoyl)-proxyl (MSL-2) 
and 3-maleimido-proxyl (MSL-0) were purchased from 
Sigma. The molecular structure of these spin labels is 
given below. 
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2.2. Spin labeling 
Ca2+-ATPase was labeled by incubation of SRV sus- 
pensions ( ~- 30 mg of protein per ml) with the desired spin 
label, at a label to protein ratio of 2-3, for about 24 h, at 
8°C. Approximately 1 ml of the suspensions in Hepes 20 
raM, at pH 7.4, with/without NaCI, was added to an 
appropriate aliquot of the stock solution of spin label in 
ethanol (10 mM), after evaporating the solvent. In order to 
eliminate the unreacted spin labels, the samples were 
centrifugated uring 20 min at 17000 rpm and resus- 
pended in the buffer solution at least twice. The EPR 
signal of the supematant after the first washing showed 
that the quantity of unreacted spin label corresponded to
less than 10% of the total quantity of spin label added. 
Unreacted label after the second washing was less than 
1%. 
2.3. Anesthetic treatment 
The local anesthetics dibucaine and tetracaine were 
incorporated evaporating the solvent of an appropriate 
quantity of ethanol stock solutions of the drug (= 10 mM) 
and adding, thereafter, 1 ml of the suspension of vesicles 
at a protein concentration f approx. 3 mg/ml. Aliquots of 
n-alkanols were added directly. Samples were vortex mixed 
during 1 min and incubated for 2 h. Aqueous local anes- 
thetic concentrations were obtained spectrophotometrically 
after pelleting the SRV. For EPR measurements the pellets 
were redissolved in a small amout of buffer, transferred to 
capillaries and submitted to another centrifugation step. In 
the experiments o test if the anesthetics induce any radical 
reduction leading to variation of the total number of spins, 
concentrated suspensions of spin-labeled vesicles (50 mg 
protein per ml) were transferred irectly to capillaries 
containing different amounts of dibucaine and butanol 
distributed over the internal surface of the capillaries. In 
this case the last centrifugation step was skipped. 
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Samples of labeled bovine serum albumin, from Sigma, 
and hemoglobin, freshly prepared, were used to test drug 
effects on water soluble proteins. In these cases, the excess 
of free label was eliminated by column filtration (Sep- 
hadex G-20, Sigma). 9 Lauryl ether, C12E9,  used for SRV 
solubilization was purchased from Sigma. 
Table 1 
Percentual contribution of the mobile component to the spectra in Fig. 1 
% fluid component 
MSL-4 65 
MSL-2 15 
MSL-0 6 
2.4. EPR measurements and spectral analysis 
EPR measurements were carried out at room tempera- 
ture (22°C) on an X-band Varian E-9 EPR spectrometer 
interfaced with an IBM-PC for data acquisition and accu- 
mulation. A microwave power of 8 mW and modulation 
amplitude of 1 G (100 kHz) were used. 
Software for spectral manipulations was implemented 
and used in the spectral analysis. All the EPR spectra were 
normalized to the same double integral after baseline 
correction based on the experimentally proven fact that the 
total number of spins does not change with drug treatment. 
The normalized spectra were deconvoluted by spectral 
substractions, and the fractions and line shapes of the 
spectral components were obtained as described in the next 
section. 
3. Results 
3.1. Spectral analysis of Maleimide Spin Labels in sarco- 
plasmic reticulum vesicles 
Fig. 1 a, b, and c show the spectra of the three 
maleimide spin labels MSL-n (n = 4, 2, 0, respectively) in
R M 
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Fig. 1. EPR spectra of maleimide spin-labeled Ca2+-TPase of SRV. (a): 
MSL-4, (b): MSL-2, (c): MSL-0, (d): difference spectrum obtained as 
[(a)-0.375(c)] representing the mobile component and (e): difference 
spectrum obtained as [(c)-0.06(d)] representing the restricted compo- 
nent. R and M indicate the low-field peaks of the restricted and mobile 
components, respectively. All the spectra are normalized to the same 
double integral with amplification factors indicated in the figure. 
CaZ+-ATPase of SRV. The spectrum of the shorter spin 
label MSL-0 and that of the longer one MSL-4 are basi- 
cally due to spin labels in two different motional environ- 
ments: one due to motionally restricted labels interacting 
with the protein side chains or grooves, and another due to 
mobile fluid labels, which, although bound to the protein, 
have their motion slightly affected by interactions with 
side chains. For MSL-0 the proportion of the motionally 
restricted is much higher than for MSL-4. The position of 
the restricted component low-field peak (R in Fig. 1) is the 
same for both MSL-0 and MSL-4, indicating that they 
have the same rotational correlation time. Then, the EPR 
profile of the mobile component can be obtained by sub- 
tracting from the MSL-4 spectrum (a) the fraction of 
spectrum (c) which cancels the low-field line R. The 
normalized resulting profile of this subtraction is shown in 
Fig. l d. The EPR profile for the restricted component (Fig. 
le) was obtained subtracting 6% of the mobile component 
from the spectrum of MSL-0 (Fig. lc). 
The spectrum of the spin label MSL-2 (Fig. lb), with 
intermediate l ngth, has other motional components with 
intermediate values of rotational Correlation times besides 
the two components obtained above. In this case, what we 
called the fraction of mobile component is the fraction of 
spectrum (d) necessary to cancel the peak M. The fraction 
of the mobile component present in each spectrum is given 
in Table 1. 
All the spectral analyses performed to quantify the 
effects of anesthetics on the spin-labeled protein sites 
described below were based on previous normalization of 
all spectra. This is an adequate procedure if there is no 
radical reduction upon anesthetic treatment. If, in contrast, 
different motional environments have distinct levels of 
radical reduction the normalization of all spectra will lead 
to artifacts and misinterpretation. For this reason the pres- 
ence of radical reduction upon anesthetic treatment was 
tested with the three maleimide spin labels. Butanol and 
dibucaine treatments at four of the highest concentrations 
were performed irectly in the capillaries used for the EPR 
measurements and no centrifugation was performed after 
mixing. For the three spin labels the results showed that 
the double integrated intensity is the same as for untreated 
samples, within a standard eviation of 6%. Furthermore, 
the deviations from the mean have no correlation with the 
anesthetic oncentration in the samples. In conclusion, 
there is no spin label reduction in our experiments, and 
normalization of spectra is a valid procedure. 
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Fig. 2. Effect of the addition of n-butanol on the EPR spectrum of 
MSL-4-1abeled Ca 2 +-TPase of SRV and spectral nalysis. SRV in Hepes 
20 mM, KC1 100 mM at pH 7.4 and label to protein molar atio 3:1. (a) 
EPR spectrum of MSL-4-1abeled SRV treated with 400 mM butanol, (b) 
EPR spectrum of MSL-4-1abeled SRV in buffer, normalized to the same 
double integral, (c) difference spectrum obtained as [(a)-0.55(b)] (en- 
larged 4-fold) representing the restricted component. R indicates the 
low-field peak of the restricted component. 
3.2. Effects of the n-alkanols on the EPR spectrum of 
MSL-n in SRV 
n-Butanol treatment decreases the intensity of the mo- 
bile component of all the three maleimide spin labels in 
SRV and increases that of the restricted component. The 
spectrum in Fig. 2a is representative of this effect. The 
increase of the restricted component (R) shows that the 
drugs induce a strong restriction in the movement of a 
fraction of the mobile labels and not just a slight increase 
of the line widths. Actually, the increase of the restricted 
component is only observed with MSL-4 and MSL-2. The 
spreading of the restricted component spectrum over a 
much wider range of magnetic fields than the mobile one 
makes its signal to noise ratio much lower. For this reason 
the changes in the EPR spectra are quantified in terms of 
the population of mobile labels. 
The EPR spectra were analyzed by the following spec- 
tral subtractions: different fractions f of the control spec- 
trum (Fig. 2b) were subtracted from the spectra of n-butanol 
treated samples (e.g., Fig. 2a). The criterium used to obtain 
the fraction f for each alcohol concentration was elimina- 
tion of the mobile component peaks M. The results are, 
therefore, restricted profiles like the one in Fig. 2c ( f  = 0.55 
for the spectral subtraction i  Fig. 2). Thus, in the presence 
of the alcohol, only a fraction f of the population of 
mobile labels remains unaltered, while F = 1 - f  of this 
population changes to a motionally restricted state. F is, 
therefore, the fraction of the mobile spin label population 
which is altered by drug treatment. 
Fig. 3 shows the fraction F as a function of the 
concentration of n-butanol obtained from measurements 
. . . . . . . .  i . . . . . . .  
0° +?,  
0 MSL-4 T / A 
z~ MSL-2 IV /  
D ~SL-0 ~ i   0S0 
0.0 i 
0.1 1 
concentrafion (M) 
Fig. 3. Plot showing the dependence of the fraction F on the concentra- 
tion of butanol. F is the fraction of the mobile component which 
becomes restricted after butanol treatment and it is obtained, as indicated 
in the text, from the spectral analysis of the EPR profiles of the 
Ca2+-ATPase labeled with MSL. The solid curve is an aid to the eyes. 
using the three different MSL. The results obtained with 
the different labels do not apparently provide any comple- 
mentary information. These labels probably bind to the 
same sites in the protein, and the main differences among 
them are their fractions of mobile spectrum. 
There is, however, a question to be answered: is the 
observed restriction effect of the n-alkanols correlated with 
their l ip id/water  partition coefficients? Since the func- 
tional effects correlate with the hydrophobicity measured 
by this coefficient, a positive answer to this question 
would favour the hypothesis of a direct action of alkanol 
molecules on Ca2+-ATPase. To answer this question, ex- 
periments were performed with other n-alkanols, e.g., 
ethanol, n-hexanol, and n-octanol. In these cases the con- 
centrations used were those inducing maximum ATPase 
activity, Cma x [10], which are approximately proportional to 
the inverse of their l ip id/water  partition coefficients. The 
fraction F of mobile labels restricted by alcohol treatment 
at the concentration Cm, × for each n-alkanol is presented in 
Table 2, which also lists the l ip id/water  partition coeffi- 
cients and the calculated intramembrane concentration. It 
is observed that the restriction effect decreases on going 
from ethanol to octanol. While ethanol restricts almost 
50% of mobile labels, n-octanol has no effect. Moreover, 
despite n-octanol being more efficient than n-butanol in 
Table 2 
Concentrations of alkanols producing maximal ATPase activation (Cma x) ,  
intramembrane concentrations (Cm~,,), calculated as Kp-Cmax, where the 
values of the partition coefficients, Kp, were taken from [29,30], and 
fraction (F) of mobile spin labels that become restricted after treatment 
with the n-alkanols at concentrations leading to the same functional 
effects 
Alkanol C,n~ (M) c . . . .  (M) F 
Ethanol 3.0 1.4 0.47 + 0.05 
Butanol 0.3 0.96 0.31 _+ 0.05 
Hexanol 17.10 .3  0.85 0.14 --+ 0.05 
Octanol 1.6" 10 3 0.62 0.00-+0.05 
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Fig. 4. The effects of dibucaine and tetracaine treatment on the EPR 
spectrum of MSL in sarcoplasmic reticulum vesicles. F is the fraction of 
the mobile component which becomes restricted after anesthetic treat- 
ment. The closed symbols represent tetracaine while the open ones are for 
dibucaine. Circles, triangles and squares are for MSL-4, MSL-2, and 
MSL-0, respectively. Solid curves are aids to the eyes. 
perturbing the function of the enzyme, it is necessary a
n-octanol membrane concentration 10-fold higher than that 
of n-butanol in order produce the same effect on the MSL 
spectra. In fact, F = 0.31 is obtained for n-butanol at Cma x
(0.3 M), which corresponds to = 1 M in the membrane, 
while the same degree of immobilization is observed with 
30 mM octanol, which corresponds to = 11 M in the 
membrane. The answer to our question is, therefore, no. 
The n-alkanols restriction effects on Ca 2 ÷-ATPase are not 
correlated with their lipid/water partition coefficients in 
the same way as their functional effects are. 
3.3. Effect of dibucaine and tetracaine on the EPR spec- 
trum of MSL-n in SRV 
The effects of dibucaine and tetracaine on EPR spectra 
of maleimide spin-labeled SRV are similar to those ob- 
served for alkanol-treatment. Local anesthetics also induce 
changes in the sites to which the labels are bound such that 
the mobile labels become more restricted. The plot of the 
fraction F as a function of the anesthetic oncentration 
(dibucaine and tetracaine) is shown in Fig. 4. The struc- 
tural changes observed by EPR occur at concentrations at
which these local anesthetics perturb the enzymatic func- 
tion [17,31,32]. Contrary to the alkanols, the same degree 
of spin label restriction is observed for almost the same 
membranous concentrations. In fact, the effects of tetra- 
caine and dibucaine are approximately equivalent for con- 
centrations which are related by the same factor as the 
membrane/buffer partition coefficients for these drugs, 
e.g., the ratio of concentrations (tetracaine /dibucaine) 
giving place to spin label restriction such that F = 0.3 is in 
the range of 3 to 4, which coincides approximately with 
the ratio of partition coefficients estimated from the mea- 
surements of aqueous concentrations. This ratio is also 
close to that of concentrations producing similar functional 
disturbances on the enzyme [17,31,32]. This indicates a 
correlation between the effects on the protein and the 
changes induced in enzyme function. 
Salt and pH effects were tested on dibucaine-treated 
SRV. Salt effects were not significant. The EPR spectrum 
of MSL-4 in control samples does not change for pH 
values above 6.4, while, for low pH (= 5.3), the fraction 
of the mobile component is much smaller and does not 
change upon dibucaine treatment. The restriction effect of 
dibucaine was detected for 6.4 < pH < 9.0, suggesting that 
both the charged and neutral forms of the drug interact 
with the protein. 
We also obtained spectra of spin-labeled SRV, solubi- 
lized with CI2E9, as well as those of other soluble pro- 
teins, such as bovine serum albumin and hemoglobin, 
before and after dibucaine, and butanol treatment. In these 
cases, no relevant alterations were observed, even at con- 
centrations much higher than those used to treat SRV 
samples. These negative results indicate that the effects 
observed in the case of the Ca2÷-ATPase are not a general 
property of proteins and that the action of these drugs may 
be associated to the presence of a lipidic environment. 
4. Discussion 
The interaction of anesthetics with sarcoplasmic reticu- 
lum vesicles is studied using maleimide-derivative spin 
labels with three different lengths. The spin labels cova- 
lently bind to the more reactive cysteines from Ca 2+- 
ATPase. The most probable localization for these cysteines 
is in the protein globular domains, where SH groups are 
abundant and more exposed to the aqueous phase than the 
alpha-helix domains which cross the membrane [24,25]. 
Since MSL-4 is sensitive to the lipid environment and to 
the oligomeric state of Ca2÷-ATPase [26] at least one of 
the labelling sites should be near the lipid protein interface. 
Labels at each binding site can have more than one 
motional environment, and the fraction of labels in each 
motional environment, as well as their respective correla- 
tion times, depend on the length of the label [33]. In 
Ca2÷-ATPase, about 35% of the longer one, MSL-4, still 
are in a strongly restricted motional environment (Table 1), 
and this fraction increases with decreasing label length. In 
the EPR time scale the severely restricted motional envi- 
ronment do not detect any further estriction. 
Both classes of studied drugs, e.g. alkanols, which share 
properties of general anesthetics, and tertiary amine, local 
anesthetics, restrict the motion of maleimide spin labels 
bound to SR Ca2÷-ATPase, and this observed effect is 
quantitatively analyzed through the modifications induced 
in the spectral component of the most mobile labels. Spin 
label restriction was previously observed in red blood cells 
treated with anesthetics [34], and attributed to protein 
conformational changes. In Ca2+-ATPase, the restriction 
effects are due to changes in regions of the protein adja- 
cent to the more reactive cysteine residues. They could be 
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caused either by direct binding of the drug to protein sites 
near those residues, or by indirect effects due to propa- 
gated disturbance occurring on binding to other protein 
sites or to the lipidic matrix. The negative results we 
obtained with solubilized proteins treated with dibucaine 
indicate that the lipidic environment modulates the restric- 
tion. Drug induced aggregation of the Ca2+-ATPase could 
be restricting MSL motion. In fact, Kutchai et al. reported 
the formation of large oligomers of Ca 2 +-ATPase induced 
by local anesthetics, and a concentration dependent bipha- 
sic behaviour of dissociation or aggregation of small 
oligomers by hexanol [21]. 
Correlation of the restriction effect with functional ef- 
fects was tested. Since correlation was found in the case of 
the tertiary amine local anesthetics, but not in the case of 
n-alkanols, we discuss them separately. 
The good correlation between -alkanol effects on AT- 
Pase activity and their lipid/buffer partition coefficients 
[10] suggests that drug action on the enzymatic function of 
SR Ca2+-ATPase is related to a hydrophobic site. Recently 
developed studies on the action of n-alkanols at the 
lipid/protein interface of this same enzyme [12] using 
spin-labeled phosphatidylcholine (14-PCSL), showed that 
the n-alkanols displace and fluidize interfacial lipids creat- 
ing annular fluid clusters, and that these changes correlate 
with the changes in activity and calcium permeability. Our 
results show that n-alkanols also disturb the protein induc- 
ing a motional restriction at sites near the most reactive 
cysteine residues. Nevertheless, the effects on the 
maleimide spin-labeled protein sites do not correlate with 
the functional effects. At the respective concentrations 
producing maximal activity [10,11], n-alkanols are far 
from producing the same degree of MSL restriction. The 
observation that the structural alteration detected by these 
protein-bound labels is not related to the alkanol induced 
functional changes indicates that the restriction of protein- 
bound spin labels is not a consequence of modulation of 
protein conformation by lipid-protein interactions. This 
conclusion favours the hypothesis that n-alkanols act on 
integral proteins through the lipid/protein interface but the 
presence of other function related protein site is not ex- 
cluded. It also suggests a secondary site for alkanol bind- 
ing at the protein, not related to the fluidization of the 
annular lipids. Hexanol was reported to dissociate or ag- 
gregate small oligomers of the Ca 2 +-ATPase [21], depend- 
ing on its concentration. We observed MSL restriction in 
the range of concentrations reported to induce dissociation. 
Thus, aggregation is probably not the cause of MSL 
restriction. 
According to the results presented in Fig. 4, the local 
anesthetics dibucaine and tetracaine induce MSL restric- 
tion at functionally relevant concentrations. Moreover, 
equivalent degrees of restriction take place at dibucaine 
and tetracaine concentrations related by their lipid/buffer 
partition coefficients, obeying the rule: same intra- 
membrane concentration, same effect. For tertiary amine 
local anesthetics there is also a good correlation between 
lipid/buffer partition coefficients and functional effects 
[17,31,32]. The observed restriction is, therefore, related to 
functional effects. The lipid/protein interface was tested 
for dibucaine binding using the phosphatidylcholine spin 
label 14-PCSL (unpublished result) but no changes were 
observed at concentrations affecting calcium uptake and 
ATPase activity. On the other hand, recent fluorescence 
measurements [35] showed that the highest affinity site for 
dibucaine in SRV is a lipid site near the membrane sur- 
face. Actually, a surface site for the local anesthetic ex- 
plains why the label bound at the 14th carbon is not able to 
detect eventual changes at the lipid/protein interface. Some 
recent studies [17,19,36] suggest specific interactions of 
local anesthetics with membrane proteins, but in all cases 
protein/lipid interfacial sites are not excluded. The in- 
duced formation of Ca2+-ATPase oligomers by local anes- 
thetics, reported by [21], can account for the function 
related restriction effects reported here. The local anes- 
thetic binding site that better accounts for the results 
obtained by the different authors is a protein site at the 
lipid/protein interface. 
Despite the absence of information on the exact local- 
ization of the spin labels in Ca2+-ATPase, pertinent con- 
clusions are derived from our experiments. There are 
alkanol interacting sites in Ca2+-ATPase not correlated 
with hydrophobicity or functional changes. In contrast, 
local anesthetics induce structural changes in the enzyme, 
which are coupled to functional disturbances. The most 
reasonable explanation is that these function related 
changes occur through local anesthetic binding to a super- 
ficial site at the lipid/protein interface. We propose that 
functional effects of both alkanols and local anesthetics are 
induced through the lipid/protein interface. The distur- 
bance they produce in the lipid/protein interface is, how- 
ever, different. Local anesthetics uperficially bind to 
membrane lipids affecting protein domains, while alkanols 
deeply disturb the lipidic hydrophobic chains at the 
lipid/protein interface. 
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